Font Size


Latest Pharmacy News and Notices

The latest pharmacy provider billing updates and news notices will be posted here. Please check daily for updates. 


New Medication Management Component of Elderly & Disabled (E&D) Waiver

Exciting Opportunity for MS Medicaid Pharmacy Providers: New Medication Management Component of Elderly & Disabled (E&D) Waiver, effective 2-1-2024. Pharmacists who are interested in participating must watch the video found here and submit an email to as follows:

Email subject: “E&D Waiver medication management”
Email body: Pharmacy Name, Address and County , Pharmacist Contact Name, Phone Number, Fax Number, Medicaid ID #, NPI#


Flovent HFA Discontinuation on the MS Medicaid Universal Preferred Drug List (PDL)

Flovent HFA (fluticasone propionate inhalation aerosol) was recently discontinued by its manufacturer, GlaxoSmithKline. This is a business decision made by GlaxoSmithKline and not related to any new safety or efficacy information.

Fluticasone propionate HFA (generic for Flovent HFA; 44, 110, & 220 mcg/act inhaled aerosol; 120 actuations with 1 canister) is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older.

Based on the discontinuation of the name brand Flovent HFA the Division of Medicaid has made the following policy changes.

1. Fluticasone HFA will remain non-preferred, however, there will be automatic approval (electronic prior authorization) of Fluticasone HFA for children aged 4- 5 years, who have a diagnosis of asthma.
2. Age waiver prior authorization submission will be required for Fluticasone HFA for children less than 4 years of age.
3. For children >6 years of age, providers should prescribe the most cost-effective drugs to the state – the preferred drugs in the Inhaled Glucocorticoid Class; Asmanex Twisthaler (mometasone), budesonide 0.25mg and 0.5mg nebulizer suspension, Pulmicort Flexhaler (budesonide), and Qvar Redihaler (beclomethasone diproprionate).

Jan. 22, 2024


PRN Updates for Pharmacy Providers – Updated Nov. 15, 2022

Medicaid allows the generic mandate requirement to be overridden for brand name narrow therapeutic index (NTI) drugs to include Coumadin, Dilantin, Lanoxin, Synthroid, and Tegretol … Read more.


Attention Pharmacy Providers! New Fiscal Agent effective October 1, 2022

The new fee-for-service (FFS) pharmacy processing information is as follows:
BIN #: 025151    PCN: DRMSPROD
Pharmacy Claims and Prior Authorization Call Center number: 1-833-660-2402
Pharmacy Prior Authorization fax number: 1-866-644-6147


Claims and Prior Authorization – Gainwell Technologies

Please contact our fiscal agent, Gainwell Technologies, for questions or problems relating to any Pharmacy Prior Authorization or POS claims issues.

Toll-free: 1-833-660-2402
Pharmacy PA Fax: 1-866-644-6147
Provider/Member Call Center: 1-800-884-3222
Provider Fax: 1-866-644-6148


Mississippi Medicaid Prescribers – registered users
If you are a Mississippi Medicaid prescriber, submit your prior authorization requests through the Gainwell Technologies provider portal.

Medicaid Office of Pharmacy Contact Information

Phone: 601-359-5253, #4
Fax: 601-359-9555